Efficacy and Safety of Upadacitinib Treatment in Adolescents with Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials
Amy S. Paller*, Barry Ladizinski, Pedro Mendes-Bastos, Elaine Siegfried, Weily Soong, Vimal H. Prajapati, Peter Lio, Jacob P. Thyssen, Eric L. Simpson, Andrew M. Platt, Eliza M. Raymundo, Jianzhong Liu, Brian M. Calimlim, Xiaohong Huang, Yihua Gu, Xiaofei Hu, Yang Yang, John C. Su, Min Zheng, Kiwako Yamamoto-HanadaHenrique D. Teixeira, Alan D. Irvine
Dive into the research topics of 'Efficacy and Safety of Upadacitinib Treatment in Adolescents with Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials'. Together they form a unique fingerprint.